期刊文献+

妥布霉素滴眼液的安全性研究 被引量:2

The safety test of tobramycin eye drops
下载PDF
导出
摘要 目的考察妥布霉素滴眼液的安全性。方法对比观察妥布霉素滴眼剂、5%辣椒酊、生理盐水局部应用、单次给药和连续给药1周对家兔眼的刺激性。结果妥布霉素滴眼液单次及多次给药对兔眼均无明显影响,双眼角膜透明,无混浊,虹膜纹理清晰,结膜无充血、水肿、分泌物。结论妥布霉素滴眼液临床应用是安全的。 Objective To test the safety effect of eye drops on rabbit eyes. Methods The effects of single-dose and multiple-doses tobramycin eye drops on rabbit eyes were observed. Results There was no obvious influence in single and multiple-doses regular irritation on rabbit eyes, both corneas were transparent without turbidness, the iris is dear, and no conjunctiva hyperemia, edema and discharge was found, Conclusion Tobramycin eye drops is safety for clinic application.
作者 曲晓梅 李梅
出处 《实用药物与临床》 CAS 2008年第1期48-49,共2页 Practical Pharmacy and Clinical Remedies
关键词 妥布霉素滴眼液 安全性 临床应用 角膜透明 Tobramycin eye drops Safety test
  • 相关文献

参考文献3

二级参考文献14

共引文献134

同被引文献13

  • 1张力军,赵坡,孙雅得,孙丽红,武平.新生儿急性泪囊炎的诊断与治疗[J].中国斜视与小儿眼科杂志,2004,12(4):182-182. 被引量:13
  • 2杨小慧.药物性角膜病变的临床分析[J].国际眼科杂志,2007,7(3):861-862. 被引量:11
  • 3Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica, 2003, 217: 89-98. 被引量:1
  • 4Congdon NG, Schein OO, yon Kulajta P, et al. Corneal complica- tions associated with ophthalmic use of nonsteroidal antiinflamma- tory drugs. J Cataract Refract Surg, 2001, 27: 622-631. 被引量:1
  • 5Zanini M, Savini G, Barboni P. Corneal melting associated with topical diclofenac use afterlaser-assisted subepithelial keratectomy. J Cataract Refract Surg, 2006, 32: 1570-1572. 被引量:1
  • 6Hsu JK, Johnston WT, Read RW, et al. Histopathology of corneal melting associated with dielofenae use after refractive surgery. J Cataract Refract Surg, 2003, 29: 250-256. 被引量:1
  • 7Lu KL, WeeWR, Sakamoto T, et al. Comparison of in vitro anti- proliferative effects of steroids and nonsteroidal antiinflammatory drugs on human keratocytes. Cornea, 1996, 15: 185-190. 被引量:1
  • 8Chen X J, Gallar J, Belmonte C. Reduction by anti-inflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation. Invest Onhthalmol Vis Sci_ 1997. 38: 1944-1953. 被引量:1
  • 9Blumenkrmlz MB, Calfin A, Hajek AS. Selection of therapeutic a- gents or intraocular prolification disease. Arch Ophthalmol, 1984, 102: 598-604. 被引量:1
  • 10Baudouin C, de Lunardo C. Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol, 1998, 82: 39-42. 被引量:1

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部